A Canadian research group is looking at the use of cannabis oil as a treatment for neuropathic pain in multiple sclerosis patients.
Using mice models, the study is investigating the pain relief properties of two types of cannabinoid oil produced by CanniMed Therapeutics specifically for chronic pain associated with multiple sclerosis. The researchers are using CanniMed 10:10 which contains equal measures of CBD (cannabidiol) and THC (tetrahydrocannabinol) and the company’s CanniMed 1:20 which only contains CBD.
The study aims to discover how effective the medical marijuana is at treating MS-associated pain and also to discover the molecular effects of the oils and exactly how it works as a pain relief treatment. Find out more about this study here.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.